chr11-1697562-A-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001012416.1(KRTAP5-6):āc.317A>Cā(p.Gln106Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,613,706 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001012416.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KRTAP5-6 | NM_001012416.1 | c.317A>C | p.Gln106Pro | missense_variant | 1/1 | ENST00000382160.1 | NP_001012416.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KRTAP5-6 | ENST00000382160.1 | c.317A>C | p.Gln106Pro | missense_variant | 1/1 | 6 | NM_001012416.1 | ENSP00000371595.1 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151840Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251480Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135914
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1461866Hom.: 2 Cov.: 32 AF XY: 0.0000261 AC XY: 19AN XY: 727224
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151840Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74158
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 08, 2023 | The c.317A>C (p.Q106P) alteration is located in exon 1 (coding exon 1) of the KRTAP5-6 gene. This alteration results from a A to C substitution at nucleotide position 317, causing the glutamine (Q) at amino acid position 106 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at